• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙GEICAM小组关于乳腺癌的流行病学研究(1990 - 1993年):埃尔阿拉莫项目

[Epidemiological study of the GEICAM group about breast cancer in Spain (1990-1993): El Alamo project].

作者信息

Martín Miguel, Llombart-Cussac Antonio, Lluch Ana, Alba Emilio, Munárriz Blanca, Tusquets Ignacio, Barnadas Agustí, Balil Anna, Dorta Javier, Picó César

机构信息

Servicio de Oncología Médica, Hospital Universitario San Carlos, Madrid, Spain.

出版信息

Med Clin (Barc). 2004 Jan 17;122(1):12-7. doi: 10.1016/s0025-7753(04)74126-3.

DOI:10.1016/s0025-7753(04)74126-3
PMID:14733868
Abstract

BACKGROUND AND OBJECTIVE

The aim of the El Alamo project was to define the demographic and clinic characteristics, treatment and evolution of women with invasive breast cancer diagnosed in hospitals of the GEICAM group (Spanish Breast Cancer Research Group) between 1990 and 1993.

PATIENTS AND METHOD

Data from 4,532 patients were included. Forms were completed according to the medical history of patients, and collected in the GEICAM scientific office, where they were added to a data base.

RESULTS

32 hospitals from 19 provinces and 11 regional communities participated in the study. Mean age of the 4,532 patients was 56.72 years, 1,428 (31.5%) were premenopausal and 2,988 (65.9%) were postmenopausal. Stage II tumors were most frequent (55.5%). Among patients with stage I, II and III at diagnosis, surgery was the first treatment in most (90.7%), radical mastectomy being the most frequent procedure performed (79.7%). 70.4% of 1941 patients with positive axillary node and 37.4% of 1,806 patients without axillary affection received adjuvant chemotherapy with or without hormone therapy.

CONCLUSIONS

El Alamo project represents the largest data base on breast cancer in Spain and the results are similar to those observed in other countries such as the USA.

摘要

背景与目的

“埃尔阿拉莫”项目的目的是明确1990年至1993年间在GEICAM组(西班牙乳腺癌研究组)各医院诊断出的浸润性乳腺癌女性患者的人口统计学和临床特征、治疗情况及病情发展。

患者与方法

纳入了4532例患者的数据。根据患者病史填写表格,并收集到GEICAM科研办公室,随后录入数据库。

结果

来自19个省和11个自治区的32家医院参与了该研究。4532例患者的平均年龄为56.72岁,其中1428例(31.5%)为绝经前患者,2988例(65.9%)为绝经后患者。II期肿瘤最为常见(55.5%)。在诊断为I期、II期和III期的患者中,大多数(90.7%)的首选治疗方法是手术,其中最常进行的手术是根治性乳房切除术(79.7%)。1941例腋窝淋巴结阳性患者中有70.4%以及1806例无腋窝受累患者中有37.4%接受了辅助化疗,部分患者还接受了激素治疗。

结论

“埃尔阿拉莫”项目是西班牙最大的乳腺癌数据库,其结果与美国等其他国家观察到的结果相似。

相似文献

1
[Epidemiological study of the GEICAM group about breast cancer in Spain (1990-1993): El Alamo project].西班牙GEICAM小组关于乳腺癌的流行病学研究(1990 - 1993年):埃尔阿拉莫项目
Med Clin (Barc). 2004 Jan 17;122(1):12-7. doi: 10.1016/s0025-7753(04)74126-3.
2
Evolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III project.在 El Alamo III 项目中,纳入了 1998 年至 2001 年期间在西班牙被诊断为早期乳腺癌的老年患者的演变情况。
Clin Transl Oncol. 2019 Dec;21(12):1746-1753. doi: 10.1007/s12094-019-02189-6. Epub 2019 Aug 5.
3
The "El Alamo" project (1990-1997): two consecutive hospital-based studies of breast cancer outcomes in Spain.“阿拉莫”项目(1990 - 1997年):西班牙两项基于医院的乳腺癌结局连续研究。
Clin Transl Oncol. 2006 Jul;8(7):508-18. doi: 10.1007/s12094-006-0051-7.
4
Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register.转移性复发性乳腺癌患者的实用预后指数:来自西班牙 GEICAM El Alamo 注册中心的 2322 例患者的回顾性分析。
Breast Cancer Res Treat. 2010 Jul;122(2):591-600. doi: 10.1007/s10549-009-0687-4. Epub 2010 Jan 10.
5
Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM).辅助化疗开始时间对乳腺癌生存的影响:西班牙乳腺癌研究小组(GEICAM)的一项阴性结果研究
Breast Cancer Res Treat. 2007 Jan;101(2):215-23. doi: 10.1007/s10549-006-9282-0. Epub 2006 Jul 6.
6
Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study.西班牙具有遗传风险特征的乳腺癌发病率:来自GEICAM“阿尔莫III”回顾性研究的分析
PLoS One. 2017 Oct 6;12(10):e0184181. doi: 10.1371/journal.pone.0184181. eCollection 2017.
7
Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in Southern India.印度南部一家社区医院浸润性乳腺癌的流行病学及治疗模式
World J Surg Oncol. 2007 May 23;5:56. doi: 10.1186/1477-7819-5-56.
8
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).初发转移性乳腺癌患者原发灶切除对生存的影响(GEICAM/El Alamo 登记研究)。
Sci Rep. 2019 Dec 27;9(1):20081. doi: 10.1038/s41598-019-55765-9.
9
Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.OTOASOR试验的八年随访结果:早期乳腺癌前哨淋巴结活检阳性后腋窝的最佳治疗——手术或放疗:一项随机、单中心、III期、非劣效性试验。
Eur J Surg Oncol. 2017 Apr;43(4):672-679. doi: 10.1016/j.ejso.2016.12.011. Epub 2017 Jan 16.
10
[Clinical analysis of resectable breast cancer: a report of 6 263 cases].可切除乳腺癌的临床分析:6263例报告
Ai Zheng. 2005 Mar;24(3):327-31.

引用本文的文献

1
Epidemiological challenges in pandemic coronavirus disease (COVID-19): Role of artificial intelligence.大流行冠状病毒病(COVID-19)中的流行病学挑战:人工智能的作用
Wiley Interdiscip Rev Data Min Knowl Discov. 2022 Jul-Aug;12(4):e1462. doi: 10.1002/widm.1462. Epub 2022 Jun 28.
2
Use of radiation treatment units in breast cancer. Changes in the last 15 years.放射治疗设备在乳腺癌治疗中的应用。过去15年的变化。
Clin Transl Oncol. 2008 Jan;10(1):47-51. doi: 10.1007/s12094-008-0152-6.
3
Municipal distribution of breast cancer mortality among women in Spain.
西班牙女性乳腺癌死亡率的城市分布情况。
BMC Cancer. 2007 May 8;7:78. doi: 10.1186/1471-2407-7-78.
4
The "El Alamo" project (1990-1997): two consecutive hospital-based studies of breast cancer outcomes in Spain.“阿拉莫”项目(1990 - 1997年):西班牙两项基于医院的乳腺癌结局连续研究。
Clin Transl Oncol. 2006 Jul;8(7):508-18. doi: 10.1007/s12094-006-0051-7.